{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Palisade Bio Announces Reverse Stock Split - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"VzSJcbBGnW\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-announces-reverse-stock-split\/\">Palisade Bio Announces Reverse Stock Split<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/palisade-bio-announces-reverse-stock-split\/embed\/#?secret=VzSJcbBGnW\" width=\"600\" height=\"338\" title=\"&#8220;Palisade Bio Announces Reverse Stock Split&#8221; &#8212; Market Newsdesk\" data-secret=\"VzSJcbBGnW\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Carlsbad,\u00a0CA, Nov. 15, 2022 (GLOBE NEWSWIRE) &#8212; Palisade Bio , Inc. \u00a0(Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced a 1-for-50 reverse split of its common stock, par value $0.01 (\u201cCommon Stock\u201d), effective at 4:01 PM ET today. Beginning on November 16, 2022, the Company\u2019s Common Stock will continue to trade on The Nasdaq Capital Market (\u201cNasdaq\u201d) on a split adjusted basis under the trading symbol \u201cPALI,\u201d but will trade under the following new CUSIP number starting November 16, 2022: 696389204. The reverse stock split was approved by Palisade Bio\u2019s stockholders at the special meeting of stockholders held on October 4, 2022. The reverse stock split is primarily intended to &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY5NzQ4NSM1MjY2MjYyIzUwMDEwOTEyMQ=="}